Home / Clinical Laboratory / Test Kits / Rapid Test Kit / Rapid Test Kit BinaxNOW™ Professional Use Antigen Test COVID-19 Ag Nasal Swab Sample 40 Tests195000
Picture of Rapid Test Kit BinaxNOW™ Professional Use Antigen Test COVID-19 Ag Nasal Swab Sample 40 Tests195000

Rapid Test Kit BinaxNOW™ Professional Use Antigen Test COVID-19 Ag Nasal Swab Sample 40 Tests195000

Rapid-Test-Kit-BinaxNOW™-Professional-Use-Antigen-Test-COVID-19-Ag-Nasal-Swab-Sample-40-Tests195000

SKU #

#1186179

MPN #

195000

Brand

Abbott Rapid Dx North America LLC

Stock

In Stock

Quantity

100

Features

TEST KIT, COVID-19 AG BINAX NOW PROFESSIONAL USE (40TEST/KT)

$238.40 USD

Product Specifications Product Usage Additional Information
Print
Attribute Name Attribute Value
McKesson # 1186179
Manufacturer # 195000
Brand BinaxNOW™ Professional Use
Manufacturer Abbott Rapid Dx North America LLC
Application Rapid Test Kit
Contents (40) Test Cards, 7.5 mL Extraction Reagent, (40) Sterile Nasal Swabs, Positive Control Swab, Negative Control Swab, Product Insert, Procedure Card
Number of Tests 40 Tests
Product Dating McKesson Acceptable Dating: we will ship >= 90 days
Reading Type Visual Read
Sample Type Nasal Swab Sample
Test Format Card Format
Test Method Lateral Flow Immunoassay
Test Name COVID-19 Ag
Test Type Antigen Test
Time To Results 15 Minute Results
UNSPSC Code 41116144
Compare Selected Items Email

Similar Items

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

  • BinaxNOW COVID-19 Ag Card is only for use under the Food and Drug Administration’s Emergency Use Authorization: https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations
  • Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet the requirements to perform moderate, high or waived complexity tests; this test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation
  • The BinaxNOW COVID-19 Ag Card is a lateral flow immunoassay for the qualitative detection of the nucleocapsid protein antigen to SARS-CoV-2 directly from anterior nasal (nares) swab specimens collected from individuals who are suspected of COVID-19 by their healthcare provider within seven days of the onset of symptoms
  • Laboratories within the United States and its territories are required to report all results to the appropriate public health authorities
  • Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status
  • Positive results do not rule out bacterial infection or co-infection with other viruses
  • Negative results should be treated as presumptive and confirmation with a molecular assay, if necessary, for patient management, may be performed
  • Negative results do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions
  • The BinaxNOW COVID-19 Ag Card is intended for use by medical professionals or trained operators who are proficient in performing rapid lateral flow tests
  • The BinaxNOW COVID-19 Ag Card does not differentiate between SARSCoV and SARS-CoV-2
  • Sensitivity (PPA) 84.6% (entire population)
  • Sensitivity (PPA) 95.6% (those with PCR cycle threshold [Ct] < 33)
  • Specificity (NPA) 98.5%
  • Onboard extraction allows the swab to be directly inserted into the test card
  • Visually read results in 15 minutes - no instrument required